Multispectroscopic methods reveal different modes of interaction of anti cancer drug mitoxantrone with Poly(dG-dC)•Poly(dG-dC) and Poly(dA-dT)•Poly(dA-dT)

被引:17
作者
Awasthi, Pamita [1 ]
Dogra, Shilpa [1 ]
Barthwal, Ritu [2 ]
机构
[1] Natl Inst Technol Hamirpur, Dept Chem, Hamirpur 177001, India
[2] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India
关键词
Drug-DNA interactions; Anticancer drug mitoxantrone; Poly(dG-dC)center dot Poly(dG-dC) and Poly(dA-dT)center dot Poly(dA-dT); Absorbance and fluorescence; Circular dichroism; Docking studies; LIGAND-DNA SYSTEMS; CALF THYMUS DNA; ETHIDIUM-BROMIDE; SEQUENCE SPECIFICITY; AGENT MITOXANTRONE; STRUCTURAL BASIS; BINDING; COMPLEXES; CD; INTERCALATION;
D O I
10.1016/j.jphotobiol.2013.07.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of mitoxantrone with alternating Poly(dG-dC)center dot Poly(dG-dC) and Poly(dA-dT)center dot Poly(dA-dT) duplex has been studied by absorption, fluorescence and Circular Dichroism (CD) spectroscopy at Drug to Phosphate base pair ratios D/P = 20.0-0.04. Binding to GC polymer occurs in two distinct modes: partial stacking characterized by red shifts of 18-23 nm at D/P = 0.2-0.8 and external binding at D/P = 1.0-20.0 whereas that to AT polymer occurs externally in the entire range of D/P. The binding constant and number of binding sites is 3.7 x 10(5) M-1, 0.3 and 1.3 x 10(4) M-1, 1.5 in GC and AT polymers, respectively at low D/P ratios. CD binding isotherms show breakpoints at D/P = 0.1, 0.5 and 0.25, 0.5 in GC and AT polymers, respectively. The intrinsic CD bands indicate that the distortions in GC polymer are significantly higher than that in AT polymer. Docking studies show partial insertion of mitoxantrone rings between to GC base pairs in alternating GC polymer. Side chains of mitoxantrone interact specifically with base pairs and DNA backbone. The studies are relevant to the understanding of suppression or inhibition of DNA cleavage on formation of ternary complex with topoisomerase-II enzyme and hence the anti cancer action. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 87
页数:10
相关论文
共 44 条
  • [41] INTERCALATING DRUGS - DNA-BINDING AND MOLECULAR PHARMACOLOGY
    WILSON, WD
    JONES, RL
    [J]. ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY, 1981, 18 : 177 - 222
  • [42] Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
    Wu, Chyuan-Chuan
    Li, Tsai-Kun
    Farh, Lynn
    Lin, Li-Ying
    Lin, Te-Sheng
    Yu, Yu-Jen
    Yen, Tien-Jui
    Chiang, Chia-Wang
    Chan, Nei-Li
    [J]. SCIENCE, 2011, 333 (6041) : 459 - 462
  • [43] Spectroscopic studies of the interactive model of methylene blue with DNA by means of β-cyclodextrin
    Zhao, GC
    Zhu, JJ
    Chen, HY
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 1999, 55 (05) : 1109 - 1117
  • [44] Structural Basis for Stabilization of the Tau Pre-mRNA Splicing Regulatory Element by Novantrone (Mitoxantrone)
    Zheng, Suxin
    Chen, Yu
    Donahue, Christine P.
    Wolfe, Michael S.
    Varani, Gabriele
    [J]. CHEMISTRY & BIOLOGY, 2009, 16 (05): : 557 - 566